Bruce Peacock, Director at Ocular Therapeutix, holds 0.00 shares in Ocular Therapeutix (Ticker: OCUL), holds 8.89K shares in Windtree Therapeutics (Ticker: WINT), holds 0.00 shares in Dicerna Pharma (Ticker: DRNA).
Bruce Peacock latest transaction was an Uninformative Buy of $127.18K.
What was Bruce Peacock's most profitable transaction?
Bruce Peacock’s most profitable transaction was an Informative Sell of OCUL stock on December 7, 2020. The return on the trade was 66.70%.
What is Bruce Peacock's role in Ocular Therapeutix?
Bruce Peacock's role in Ocular Therapeutix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.